In October 2005, Cerimon Pharmaceuticals, Inc. closed a Series A financing of $70 million with MPM Capital, Nomura Phase4 Ventures and OrbiMed Advisors.

If you are interested in learning more about Cerimon Pharmaceuticals, please contact James Welch, Chief Financial Officer at jwelch@cerimon.com.